Recent advancements in nucleic acid amplification tests (NAATs) have enabled clinicians to diagnose patients with improved accuracy for important pathogens. But are clinicians impeded by common misconceptions about available tools, or even key differences between DNA and RNA?

This supplement accurately explains the science of RNA-based testing modalities and reviews methods and results of assays for Mycoplasma genitalium, bacterial vaginosis, vulvovaginal candidiasis, Trichomonas vaginalis, and human papillomavirus.

Technology Matters: Next-Generation RNA-Based Diagnostics Improve Disease Detection

Disclosures:

References: